Banner Image

Test Directory

FISH, RUNX1T1/RUNX1 (ETO/AML1), Translocation (8;21)

Test Summary

This test is performed to detect the RUNX1T1 (ETO;8q22) and RUNX1 (AML1;21q22), translocation t(8;21), by FISH (fluorescence in situ hybridization). This assay is useful for diagnosis of acute myeloid leukemia (AML) with RUNX1T1/RUNX1 (ETO/AML1) gene fusion.

Aliases

  • N/A

Specimen Collection

Special Instructions

N/A

Preferred Specimen

5 mL whole blood or 3 mL bone marrow collected in a sodium heparin (green-top) tube

Minimum Volume

1 mL

Instructions

Clinical history and reason for referral are required with test order. Prior therapy/transplant information should be submitted with test order.

Specimen requirements: 3-5 mL whole blood or 1-3 mL bone marrow collected in a sodium heparin tube

Specimen viability decreases during transit. Send specimen to testing laboratory for viability determination. Do not freeze. Do not reject.

Note: If results are not possible, the test order may be canceled and replaced by a " Cytogenetics Communication".

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: See Collection Instructions
  • Refrigerated: See Collection Instructions
  • Frozen: See Collection Instructions

Limitations

N/A

Other Acceptable Specimens

Whole blood or Bone marrow collected in: sodium heparin (royal blue-top) tube, or sodium heparin lead-free (tan-top) tube

Unacceptable Specimens

N/A

Order Code

AML821

EPIC (Premier) Code

LAB3005

Includes

N/A

CPT Code

  • 88271 (x2)
  • 88275

Billing Code

  • 670940: 670941

CPT Statement

Methodology

Fluorescence In Situ Hybridization (FISH)

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly VA, 20153

Department

Reference Testing

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Daily; Report available: 5 days

Specimen Collection

Special Instructions

N/A

Preferred Specimen

5 mL whole blood or 3 mL bone marrow collected in a sodium heparin (green-top) tube

Minimum Volume

1 mL

Instructions

Clinical history and reason for referral are required with test order. Prior therapy/transplant information should be submitted with test order.

Specimen requirements: 3-5 mL whole blood or 1-3 mL bone marrow collected in a sodium heparin tube

Specimen viability decreases during transit. Send specimen to testing laboratory for viability determination. Do not freeze. Do not reject.

Note: If results are not possible, the test order may be canceled and replaced by a " Cytogenetics Communication".

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: See Collection Instructions
  • Refrigerated: See Collection Instructions
  • Frozen: See Collection Instructions

Limitations

N/A

Other Acceptable Specimens

Whole blood or Bone marrow collected in: sodium heparin (royal blue-top) tube, or sodium heparin lead-free (tan-top) tube

Unacceptable Specimens

N/A

Billing

CPT Code

  • 88271 (x2)
  • 88275

Billing Code

  • 670940: 670941

CPT Statement

Result Information

Methodology

Fluorescence In Situ Hybridization (FISH)

Testing Laboratory

N/A

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Daily; Report available: 5 days